首页 > 最新文献

Open Ophthalmology Journal最新文献

英文 中文
Visual Acuity, Contrast Sensitivity and Color Vision Three Years After Iodine-125 Brachytherapy for Choroidal and Ciliary Body Melanoma. 碘125近距离放射治疗脉络膜和睫状体黑色素瘤3年后的视力、对比敏感度和色觉。
IF 0.3 Q3 Medicine Pub Date : 2015-06-26 eCollection Date: 2015-01-01 DOI: 10.2174/1874364101509010131
Irena Tsui, Robert M Beardsley, Tara A McCannel, Scott C Oliver, Melissa W Chun, Steve P Lee, Phillip E Chow, Nzhde Agazaryan, Fei Yu, Bradley R Straatsma

Purpose: To report visual acuity, contrast sensitivity and color vision prior to, 1 year after, 2 years after and 3 years after iodine-125 brachytherapy for choroidal and ciliary body melanoma (CCM).

Design: Prospective interventional case series.

Participants: Thirty-seven patients (37 eyes) with CCM.

Methods: Patients had best-corrected Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity, Pelli-Robson contrast sensitivity and Hardy-Rand-Rittler color vision measurement; comprehensive ophthalmology examination; optical coherence tomography; and ultrasonography at baseline prior to, 1 year after, 2 years after and 3 years after I-125 brachytherapy.

Main outcome measures: Visual acuity, contrast sensitivity and color vision prior to, 1 year after, 2 years after and 3 years after brachytherapy.

Results: Nineteen (19) men and 18 women with mean age of 58 years (SD 13, range 30-78) prior to, 1 year after, 2 years after and 3 years after brachytherapy had mean best-corrected visual acuity of 77 letters (20/32), 65 letters (20/50), 56 letters (20/80) and 47 letters (20/125); contrast sensitivity of 30, 26, 22 and 19 letters; color vision of 26, 20, 17 and 14 test figures, respectively. Decrease in visual acuity, contrast sensitivity and color vision was statistically significant from baseline at 1 year, 2 years, and 3 years after brachytherapy. Decreased acuity at 3 years was associated with mid-choroid and macula melanoma location, ≥ 4.1 mm melanoma height, radiation maculopathy and radiation optic neuropathy.

Conclusion: 1, 2 and 3 years after brachytherapy, eyes with CCM had significantly decreased visual acuity, contrast sensitivity and color vision.

目的:报告碘125近距离放射治疗脉络膜和睫状体黑色素瘤(CCM)前、后1年、后2年和后3年的视力、对比敏感度和色觉。设计:前瞻性介入病例系列。参与者:37例(37眼)CCM患者。方法:采用最佳矫正早期治疗糖尿病视网膜病变研究(ETDRS)患者的视力、Pelli-Robson对比敏感度和Hardy-Rand-Rittler色觉测量;眼科综合检查;光学相干层析;以及I-125近距离治疗前、治疗后1年、治疗后2年和治疗后3年的基线超声检查。主要观察指标:近距离治疗前、近距离治疗后1年、近距离治疗后2年、近距离治疗后3年的视力、对比敏感度和色觉。结果:19(19)名男性和18名女性,平均年龄58岁(SD 13,范围30-78),近距离治疗前、治疗后1年、治疗后2年和治疗后3年的平均最佳矫正视力分别为77字母(20/32)、65字母(20/50)、56字母(20/80)和47字母(20/125);对比敏感度为30、26、22、19个字母;色觉分别为26、20、17、14个测试图。近距离治疗后1年、2年和3年的视力、对比敏感度和色觉较基线有统计学意义。3年视力下降与中脉络膜和黄斑黑色素瘤位置、黑色素瘤高度≥4.1 mm、放射性黄斑病变和放射性视神经病变有关。结论:近距离治疗后1、2、3年,CCM患者的视力、对比敏感度和色觉均明显下降。
{"title":"Visual Acuity, Contrast Sensitivity and Color Vision Three Years After Iodine-125 Brachytherapy for Choroidal and Ciliary Body Melanoma.","authors":"Irena Tsui,&nbsp;Robert M Beardsley,&nbsp;Tara A McCannel,&nbsp;Scott C Oliver,&nbsp;Melissa W Chun,&nbsp;Steve P Lee,&nbsp;Phillip E Chow,&nbsp;Nzhde Agazaryan,&nbsp;Fei Yu,&nbsp;Bradley R Straatsma","doi":"10.2174/1874364101509010131","DOIUrl":"https://doi.org/10.2174/1874364101509010131","url":null,"abstract":"<p><strong>Purpose: </strong>To report visual acuity, contrast sensitivity and color vision prior to, 1 year after, 2 years after and 3 years after iodine-125 brachytherapy for choroidal and ciliary body melanoma (CCM).</p><p><strong>Design: </strong>Prospective interventional case series.</p><p><strong>Participants: </strong>Thirty-seven patients (37 eyes) with CCM.</p><p><strong>Methods: </strong>Patients had best-corrected Early Treatment Diabetic Retinopathy Study (ETDRS) visual acuity, Pelli-Robson contrast sensitivity and Hardy-Rand-Rittler color vision measurement; comprehensive ophthalmology examination; optical coherence tomography; and ultrasonography at baseline prior to, 1 year after, 2 years after and 3 years after I-125 brachytherapy.</p><p><strong>Main outcome measures: </strong>Visual acuity, contrast sensitivity and color vision prior to, 1 year after, 2 years after and 3 years after brachytherapy.</p><p><strong>Results: </strong>Nineteen (19) men and 18 women with mean age of 58 years (SD 13, range 30-78) prior to, 1 year after, 2 years after and 3 years after brachytherapy had mean best-corrected visual acuity of 77 letters (20/32), 65 letters (20/50), 56 letters (20/80) and 47 letters (20/125); contrast sensitivity of 30, 26, 22 and 19 letters; color vision of 26, 20, 17 and 14 test figures, respectively. Decrease in visual acuity, contrast sensitivity and color vision was statistically significant from baseline at 1 year, 2 years, and 3 years after brachytherapy. Decreased acuity at 3 years was associated with mid-choroid and macula melanoma location, ≥ 4.1 mm melanoma height, radiation maculopathy and radiation optic neuropathy.</p><p><strong>Conclusion: </strong>1, 2 and 3 years after brachytherapy, eyes with CCM had significantly decreased visual acuity, contrast sensitivity and color vision.</p>","PeriodicalId":46347,"journal":{"name":"Open Ophthalmology Journal","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2015-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/15/ce/TOOPHTJ-9-131.PMC4541296.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33953058","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Long Term Results of Visual Field Progression Analysis in Open Angle Glaucoma Patients Under Treatment. 开角型青光眼治疗后视野进展的长期结果分析。
IF 0.3 Q3 Medicine Pub Date : 2015-06-26 eCollection Date: 2015-01-01 DOI: 10.2174/1874364101509010116
Tolga Kocatürk, Sinan Bekmez, Merve Katrancı, Harun Çakmak, Volkan Dayanır

Purpose: To evaluate visual field progression with trend and event analysis in open angle glaucoma patients under treatment.

Materials and methods: Fifteen year follow-up results of 408 eyes of 217 glaucoma patients who were followed at Adnan Menderes University, Department of Ophthalmology between 1998 and 2013 were analyzed retrospectively. Visual field data were collected for Mean Deviation (MD), Visual Field Index (VFI), and event occurrence.

Results: There were 146 primary open-angle glaucoma (POAG), 123 pseudoexfoliative glaucoma (XFG) and 139 normal tension glaucoma (NTG) eyes. MD showed significant change in all diagnostic groups (p<0.001). The difference of VFI between first and last examinations were significantly different in POAG (p<0.001), and XFG (p<0.003) but not in NTG. VFI progression rates were -0.3, -0.43, and -0.2 % loss/year in treated POAG, XFG, and NTG, respectively. The number of empty triangles were statistically different between POAG-NTG (p=0.001), and XFG-NTG (p=0.002) groups. The number of half-filled (p=0.002), and full-filled (p=0.010) triangles were significantly different between XFG-NTG groups.

Conclusion: Functional long-term follow-up of glaucoma patients can be monitored with visual field indices. We herein report our fifteen year follow-up results in open angle glaucoma.

目的:评价开角型青光眼患者在治疗过程中视野恶化的趋势及事件分析。材料与方法:回顾性分析1998 - 2013年在Adnan Menderes大学眼学系随访的217例青光眼患者408只眼15年随访结果。收集视野数据,包括平均偏差(MD)、视野指数(VFI)和事件发生情况。结果:原发性开角型青光眼(POAG) 146眼,假剥脱型青光眼(XFG) 123眼,正常张力型青光眼(NTG) 139眼。结论:视野指数可以监测青光眼患者的功能性长期随访。我们在此报告开角型青光眼15年的随访结果。
{"title":"Long Term Results of Visual Field Progression Analysis in Open Angle Glaucoma Patients Under Treatment.","authors":"Tolga Kocatürk,&nbsp;Sinan Bekmez,&nbsp;Merve Katrancı,&nbsp;Harun Çakmak,&nbsp;Volkan Dayanır","doi":"10.2174/1874364101509010116","DOIUrl":"https://doi.org/10.2174/1874364101509010116","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate visual field progression with trend and event analysis in open angle glaucoma patients under treatment.</p><p><strong>Materials and methods: </strong>Fifteen year follow-up results of 408 eyes of 217 glaucoma patients who were followed at Adnan Menderes University, Department of Ophthalmology between 1998 and 2013 were analyzed retrospectively. Visual field data were collected for Mean Deviation (MD), Visual Field Index (VFI), and event occurrence.</p><p><strong>Results: </strong>There were 146 primary open-angle glaucoma (POAG), 123 pseudoexfoliative glaucoma (XFG) and 139 normal tension glaucoma (NTG) eyes. MD showed significant change in all diagnostic groups (p<0.001). The difference of VFI between first and last examinations were significantly different in POAG (p<0.001), and XFG (p<0.003) but not in NTG. VFI progression rates were -0.3, -0.43, and -0.2 % loss/year in treated POAG, XFG, and NTG, respectively. The number of empty triangles were statistically different between POAG-NTG (p=0.001), and XFG-NTG (p=0.002) groups. The number of half-filled (p=0.002), and full-filled (p=0.010) triangles were significantly different between XFG-NTG groups.</p><p><strong>Conclusion: </strong>Functional long-term follow-up of glaucoma patients can be monitored with visual field indices. We herein report our fifteen year follow-up results in open angle glaucoma.</p>","PeriodicalId":46347,"journal":{"name":"Open Ophthalmology Journal","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2015-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/80/c9/TOOPHTJ-9-116.PMC4541337.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34124429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Use of PocketMaker Microkeratome for Creation of Corneal Pocket for Foldable Keratoprosthesis KeraKlear Implantation - Case Series. 应用PocketMaker Microkeratome制造可折叠人工角膜植入角膜袋-案例系列。
IF 0.3 Q3 Medicine Pub Date : 2015-06-26 eCollection Date: 2015-01-01 DOI: 10.2174/1874364101509010126
Pavel Studeny, Deli Krizova, Pavel Kuchynka

Purpose: To describe a surgical method for corneal pocket creation for KeraKlear keratoprosthesis implantation by PocketMaker microkeratome.

Methods: We implanted keratoprosthesis KeraKlear in 3 patients. In all cases, we used a microkeratome PocketMaker to create a corneal pocket, where the incision was made at a depth of 300 µm with a vibrating diamond blade.

Results: Although corneas have been extensively opaque and vascularized, in all three cases we successfully performed suction of the microkeratome system and created a corneal pocket without any difficulties. Subsequent keratoprosthesis implantations were performed without any problems.

Conclusion: The technique is simple, relatively cheap, and the creation of the corneal pocket is possible even in patients with vascularized and opaque cornea.

目的:介绍一种应用PocketMaker微角膜刀在人工角膜植入中形成角膜袋的手术方法。方法:对3例患者植入人工角膜。在所有病例中,我们使用microkeratome PocketMaker来创建一个角膜口袋,在那里用振动金刚石刀片在300微米的深度上做切口。结果:虽然角膜已广泛不透明且血管化,但在所有三个病例中,我们都成功地进行了微角膜体系统的吸吸并无任何困难地创建了角膜袋。随后的角膜假体植入没有任何问题。结论:该技术简单,相对便宜,即使是血管化和不透明的角膜患者也可以制造角膜袋。
{"title":"Use of PocketMaker Microkeratome for Creation of Corneal Pocket for Foldable Keratoprosthesis KeraKlear Implantation - Case Series.","authors":"Pavel Studeny,&nbsp;Deli Krizova,&nbsp;Pavel Kuchynka","doi":"10.2174/1874364101509010126","DOIUrl":"https://doi.org/10.2174/1874364101509010126","url":null,"abstract":"<p><strong>Purpose: </strong>To describe a surgical method for corneal pocket creation for KeraKlear keratoprosthesis implantation by PocketMaker microkeratome.</p><p><strong>Methods: </strong>We implanted keratoprosthesis KeraKlear in 3 patients. In all cases, we used a microkeratome PocketMaker to create a corneal pocket, where the incision was made at a depth of 300 µm with a vibrating diamond blade.</p><p><strong>Results: </strong>Although corneas have been extensively opaque and vascularized, in all three cases we successfully performed suction of the microkeratome system and created a corneal pocket without any difficulties. Subsequent keratoprosthesis implantations were performed without any problems.</p><p><strong>Conclusion: </strong>The technique is simple, relatively cheap, and the creation of the corneal pocket is possible even in patients with vascularized and opaque cornea.</p>","PeriodicalId":46347,"journal":{"name":"Open Ophthalmology Journal","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2015-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/07/a8/TOOPHTJ-9-126.PMC4541297.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33950419","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
The Effect of Age, Gender, Refractive Status and Axial Length on the Measurements of Hertel Exophthalmometry. 年龄、性别、屈光状态及眼轴长度对Hertel刺眼测量结果的影响。
IF 0.3 Q3 Medicine Pub Date : 2015-05-29 eCollection Date: 2015-01-01 DOI: 10.2174/1874364101509010113
Omer Karti, Ozlem B Selver, Eyyup Karahan, Mehmet O Zengin, Murat Uyar

Purpose: To evaluate the normal distribution of exophthalmometric values in Turkish adult population and the effect of age, gender, refractive status and axial length on globe position.

Methods: One hundred and twenty-two males and 114 healthy females with age ranging from 18 to 87 years were included in the study. The study population was recruited from patients presenting to our institution for routine refractive examination. Hertel exophthalmometer was used to measure the degree of ocular protrusion. Effect of age, refractive error, interpupillary distance, and axial length on globe position was detected with linear regression analyses.

Results: The mean Hertel exophthalmometric size was 15.7+2.6 mm (range; 11 to 21 mm). The mean value for males was 16.1±2.6 mm (range; 11 to 21 mm), and for females 15.5±2.6 mm (range; 11 to 20 mm). The mean distance between the lateral rims of the orbit was 102 + 5.1 mm (range; 88 to 111mm). The mean exophthalmometric values were not statistically different in males and females. Age and mean spherical equivalents were negatively correlated with exophthalmometric measurements. Axial length was positively correlated with exophthalmometric measurements.

Conclusion: The exophthalmometric measurement of the eye is affected by the age, spherical equivalent and the axial length. Standard normative values of the Hertel exophthalmometric measurements should be reevaluated with larger samples.

目的:探讨土耳其成年人的突眼值正态分布及年龄、性别、屈光状态和眼轴长度对眼球位置的影响。方法:男性122人,健康女性114人,年龄18 ~ 87岁。研究人群是从到我们机构进行常规屈光检查的患者中招募的。用Hertel凸出眼计测量眼球突出程度。采用线性回归分析检测年龄、屈光不正、瞳孔间距和眼轴长度对眼球位置的影响。结果:平均Hertel眼膨出尺寸15.7±2.6 mm(范围;11至21毫米)。男性平均值为16.1±2.6 mm(范围;11至21毫米),雌性15.5±2.6毫米(范围;11至20毫米)。眼眶外侧缘之间的平均距离为102 + 5.1 mm(范围;88 ~ 111毫米)。男性和女性的平均刺眼值无统计学差异。年龄和平均球当量与远视测量呈负相关。眼轴长度与刺眼测量值呈正相关。结论:年龄、球当量和眼轴长度对眼球的刺眼测量结果有影响。应该用更大的样本重新评估Hertel刺眼测量的标准规范值。
{"title":"The Effect of Age, Gender, Refractive Status and Axial Length on the Measurements of Hertel Exophthalmometry.","authors":"Omer Karti,&nbsp;Ozlem B Selver,&nbsp;Eyyup Karahan,&nbsp;Mehmet O Zengin,&nbsp;Murat Uyar","doi":"10.2174/1874364101509010113","DOIUrl":"https://doi.org/10.2174/1874364101509010113","url":null,"abstract":"<p><strong>Purpose: </strong>To evaluate the normal distribution of exophthalmometric values in Turkish adult population and the effect of age, gender, refractive status and axial length on globe position.</p><p><strong>Methods: </strong>One hundred and twenty-two males and 114 healthy females with age ranging from 18 to 87 years were included in the study. The study population was recruited from patients presenting to our institution for routine refractive examination. Hertel exophthalmometer was used to measure the degree of ocular protrusion. Effect of age, refractive error, interpupillary distance, and axial length on globe position was detected with linear regression analyses.</p><p><strong>Results: </strong>The mean Hertel exophthalmometric size was 15.7+2.6 mm (range; 11 to 21 mm). The mean value for males was 16.1±2.6 mm (range; 11 to 21 mm), and for females 15.5±2.6 mm (range; 11 to 20 mm). The mean distance between the lateral rims of the orbit was 102 + 5.1 mm (range; 88 to 111mm). The mean exophthalmometric values were not statistically different in males and females. Age and mean spherical equivalents were negatively correlated with exophthalmometric measurements. Axial length was positively correlated with exophthalmometric measurements.</p><p><strong>Conclusion: </strong>The exophthalmometric measurement of the eye is affected by the age, spherical equivalent and the axial length. Standard normative values of the Hertel exophthalmometric measurements should be reevaluated with larger samples.</p>","PeriodicalId":46347,"journal":{"name":"Open Ophthalmology Journal","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2015-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2174/1874364101509010113","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33400890","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Ocular Surface as Barrier of Innate Immunity. 眼表作为先天免疫屏障。
IF 0.3 Q3 Medicine Pub Date : 2015-05-15 eCollection Date: 2015-01-01 DOI: 10.2174/1874364101509010049
Rodrigo Bolaños-Jiménez, Alejandro Navas, Erika Paulina López-Lizárraga, Francesc March de Ribot, Alexandra Peña, Enrique O Graue-Hernández, Yonathan Garfias

Sight is one of the most important senses that human beings possess. The ocular system is a complex structure equipped with mechanisms that prevent or limit damage caused by physical, chemical, infectious and environmental factors. These mechanisms include a series of anatomical, cellular and humoral factors that have been a matter of study. The cornea is not only the most powerful and important lens of the optical system, but also, it has been involved in many other physiological and pathological processes apart from its refractive nature; the morphological and histological properties of the cornea have been thoroughly studied for the last fifty years; drawing attention in its molecular characteristics of immune response. This paper will review the anatomical and physiological aspects of the cornea, conjunctiva and lacrimal apparatus, as well as the innate immunity at the ocular surface.

视觉是人类最重要的感官之一。眼系统是一个复杂的结构,具有防止或限制物理、化学、感染和环境因素造成的损害的机制。这些机制包括一系列解剖、细胞和体液因素,这些都是研究的问题。角膜不仅是光学系统中最强大、最重要的晶状体,而且除了它的折射性质外,还参与了许多其他的生理和病理过程;近五十年来,人们对角膜的形态学和组织学特性进行了深入的研究;其免疫反应的分子特征引起人们的关注。本文将对角膜、结膜和泪器的解剖和生理方面以及眼表的先天免疫进行综述。
{"title":"Ocular Surface as Barrier of Innate Immunity.","authors":"Rodrigo Bolaños-Jiménez,&nbsp;Alejandro Navas,&nbsp;Erika Paulina López-Lizárraga,&nbsp;Francesc March de Ribot,&nbsp;Alexandra Peña,&nbsp;Enrique O Graue-Hernández,&nbsp;Yonathan Garfias","doi":"10.2174/1874364101509010049","DOIUrl":"https://doi.org/10.2174/1874364101509010049","url":null,"abstract":"<p><p>Sight is one of the most important senses that human beings possess. The ocular system is a complex structure equipped with mechanisms that prevent or limit damage caused by physical, chemical, infectious and environmental factors. These mechanisms include a series of anatomical, cellular and humoral factors that have been a matter of study. The cornea is not only the most powerful and important lens of the optical system, but also, it has been involved in many other physiological and pathological processes apart from its refractive nature; the morphological and histological properties of the cornea have been thoroughly studied for the last fifty years; drawing attention in its molecular characteristics of immune response. This paper will review the anatomical and physiological aspects of the cornea, conjunctiva and lacrimal apparatus, as well as the innate immunity at the ocular surface. </p>","PeriodicalId":46347,"journal":{"name":"Open Ophthalmology Journal","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2015-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c4/fc/TOOPHTJ-9-49.PMC4484240.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34276360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 42
Present and New Treatment Strategies in the Management of Glaucoma. 青光眼治疗的新、新策略。
IF 0.3 Q3 Medicine Pub Date : 2015-05-15 eCollection Date: 2015-01-01 DOI: 10.2174/1874364101509010089
Kolko M

Glaucoma is a neurodegenerative disease characterized by retinal ganglion cell (RGC) death and axonal loss. It remains a major cause of blindness worldwide. All current modalities of treatment are focused on lowering intraocular pressure (IOP), and it is evident that increased IOP is an important risk factor for progression of the disease. However, it is clear that a significant number of glaucoma patients show disease progression despite of pressure lowering treatments. Much attention has been given to the development of neuroprotective treatment strategies, but the identification of such has been hampered by lack of understanding of the etiology of glaucoma. Hence, in spite of many attempts no neuroprotective drug has yet been clinically approved. Even though neuroprotection is without doubt an important treatment strategy, many glaucoma subjects are diagnosed after substantial loss of RGCs. In this matter, recent approaches aim to rescue RGCs and regenerate axons in order to restore visual function in glaucoma. The present review seeks to provide an overview of the present and new treatment strategies in the management of glaucoma. The treatment strategies are divided into current available glaucoma medications, new pressure lowering targets, prospective neuroprotective interventions, and finally possible neuroregenrative strategies.

青光眼是一种以视网膜神经节细胞(RGC)死亡和轴突丧失为特征的神经退行性疾病。它仍然是全世界失明的一个主要原因。目前所有的治疗方式都集中在降低眼压(IOP)上,很明显,眼压升高是疾病进展的重要危险因素。然而,有相当数量的青光眼患者在接受降压治疗后病情仍有进展。神经保护治疗策略的发展受到了很大的关注,但由于缺乏对青光眼病因的了解,这种治疗策略的识别受到了阻碍。因此,尽管进行了许多尝试,但尚未有神经保护药物获得临床批准。尽管神经保护无疑是一种重要的治疗策略,但许多青光眼患者是在RGCs大量丧失后才被诊断出来的。在这个问题上,最近的方法旨在挽救RGCs和再生轴突,以恢复青光眼的视觉功能。本文综述了目前青光眼的治疗策略和新的治疗策略。治疗策略分为目前可用的青光眼药物、新的降压靶点、预期的神经保护干预以及最后可能的神经再生策略。
{"title":"Present and New Treatment Strategies in the Management of Glaucoma.","authors":"Kolko M","doi":"10.2174/1874364101509010089","DOIUrl":"https://doi.org/10.2174/1874364101509010089","url":null,"abstract":"<p><p>Glaucoma is a neurodegenerative disease characterized by retinal ganglion cell (RGC) death and axonal loss. It remains a major cause of blindness worldwide. All current modalities of treatment are focused on lowering intraocular pressure (IOP), and it is evident that increased IOP is an important risk factor for progression of the disease. However, it is clear that a significant number of glaucoma patients show disease progression despite of pressure lowering treatments. Much attention has been given to the development of neuroprotective treatment strategies, but the identification of such has been hampered by lack of understanding of the etiology of glaucoma. Hence, in spite of many attempts no neuroprotective drug has yet been clinically approved. Even though neuroprotection is without doubt an important treatment strategy, many glaucoma subjects are diagnosed after substantial loss of RGCs. In this matter, recent approaches aim to rescue RGCs and regenerate axons in order to restore visual function in glaucoma. The present review seeks to provide an overview of the present and new treatment strategies in the management of glaucoma. The treatment strategies are divided into current available glaucoma medications, new pressure lowering targets, prospective neuroprotective interventions, and finally possible neuroregenrative strategies. </p>","PeriodicalId":46347,"journal":{"name":"Open Ophthalmology Journal","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2015-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/54/97/TOOPHTJ-9-89.PMC4460216.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33383143","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 35
Editorial New Advances in Diagnosis and Management of Glaucoma. 青光眼诊断与治疗的新进展。
IF 0.3 Q3 Medicine Pub Date : 2015-05-15 eCollection Date: 2015-01-01 DOI: 10.2174/1874364101509010056
M Reza Razeghinejad, Mohammad H Nowroozzadeh
Glaucoma is the first cause of unemendable visual disability and blindness worldwide [1]. If glaucoma is detected at early stages, the visual disability can be prevented or postponed, and consequently its social, economic, and psychic burdens diminished. Although glaucoma is a complex and poorly understood disorder, the primary goal of therapy is lowering Intraocular Pressure (IOP), which is not only one of the most significant risk factors in development of the disease, but also the only modifiable one. Glaucoma is a chronic disease that must be longitudinally assessed and treated based on the appearance of the optic nerve head and evaluation of its function. Traditionally, optic disc evaluation and visual field test along with IOP measurement have been used for glaucoma diagnosis and monitoring. These tests are still of great value in the field of glaucoma, but are subjected to considerable measurement errors, because visual field is a subjective test that requires patient cooperation, and optic disc evaluation is an objective but observer-dependent test. Although visual field testing has been widely used for diagnosis, staging and monitoring the disease, in many patients visual field losses only become detectable after a substantial number of optic nerve fibers has been lost. Therefore, early identification of structural damage to the optic disc and retinal nerve fiber layer is paramount for an early diagnosis of the disease. Heidelberg Retina Tomograph is an objective, observer-independent method for measurement of optic disc parameters, which allows detecting subtle changes in optic nerve head configuration, and hence earlier detection of glaucoma progression [2]. Optical coherence tomography can reliably measure peripapillary retinal nerve fiber layer and macular thickness as an anatomical proxy for visual field test. This test is objective, highly repeatable, and requires less patient cooperation than visual field. Other limitations of visual field such as low vision are also less problematic in these objective tests [3, 4]. However, these devices have their own limitations which should be taken into account while interpreting them. With few exceptions, medical therapy is the first treatment modality in glaucoma patients. Despite a number of pharmacological options, failure of medical treatment is a significant issue owing to drug ineffectiveness and intolerance, but also to poor patient compliance and persistence. Although after introduction of new drugs in mid-1990s, the global number of glaucoma operations has decreased, particularly in the western countries [1], we still need medications with higher potency and fewer side effects. Considering glaucoma as a neurodegenerative disorder, new efforts have been made to prevent or reverse retinal nerve fiber layer loss through neuroprotective or neuroregenerative therapies [5]. Patients with an uncontrolled IOP despite implementing medical and laser therapy need a surgical interventi
{"title":"Editorial New Advances in Diagnosis and Management of Glaucoma.","authors":"M Reza Razeghinejad,&nbsp;Mohammad H Nowroozzadeh","doi":"10.2174/1874364101509010056","DOIUrl":"https://doi.org/10.2174/1874364101509010056","url":null,"abstract":"Glaucoma is the first cause of unemendable visual disability and blindness worldwide [1]. If glaucoma is detected at early stages, the visual disability can be prevented or postponed, and consequently its social, economic, and psychic burdens diminished. Although glaucoma is a complex and poorly understood disorder, the primary goal of therapy is lowering Intraocular Pressure (IOP), which is not only one of the most significant risk factors in development of the disease, but also the only modifiable one. \u0000 \u0000Glaucoma is a chronic disease that must be longitudinally assessed and treated based on the appearance of the optic nerve head and evaluation of its function. Traditionally, optic disc evaluation and visual field test along with IOP measurement have been used for glaucoma diagnosis and monitoring. These tests are still of great value in the field of glaucoma, but are subjected to considerable measurement errors, because visual field is a subjective test that requires patient cooperation, and optic disc evaluation is an objective but observer-dependent test. Although visual field testing has been widely used for diagnosis, staging and monitoring the disease, in many patients visual field losses only become detectable after a substantial number of optic nerve fibers has been lost. Therefore, early identification of structural damage to the optic disc and retinal nerve fiber layer is paramount for an early diagnosis of the disease. Heidelberg Retina Tomograph is an objective, observer-independent method for measurement of optic disc parameters, which allows detecting subtle changes in optic nerve head configuration, and hence earlier detection of glaucoma progression [2]. Optical coherence tomography can reliably measure peripapillary retinal nerve fiber layer and macular thickness as an anatomical proxy for visual field test. This test is objective, highly repeatable, and requires less patient cooperation than visual field. Other limitations of visual field such as low vision are also less problematic in these objective tests [3, 4]. However, these devices have their own limitations which should be taken into account while interpreting them. \u0000 \u0000With few exceptions, medical therapy is the first treatment modality in glaucoma patients. Despite a number of pharmacological options, failure of medical treatment is a significant issue owing to drug ineffectiveness and intolerance, but also to poor patient compliance and persistence. Although after introduction of new drugs in mid-1990s, the global number of glaucoma operations has decreased, particularly in the western countries [1], we still need medications with higher potency and fewer side effects. Considering glaucoma as a neurodegenerative disorder, new efforts have been made to prevent or reverse retinal nerve fiber layer loss through neuroprotective or neuroregenerative therapies [5]. \u0000 \u0000Patients with an uncontrolled IOP despite implementing medical and laser therapy need a surgical interventi","PeriodicalId":46347,"journal":{"name":"Open Ophthalmology Journal","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2015-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/b0/27/TOOPHTJ-9-56.PMC4460212.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33383778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A Surgical Approach to Pediatric Glaucoma. 儿童青光眼的外科治疗方法。
IF 0.3 Q3 Medicine Pub Date : 2015-05-15 eCollection Date: 2015-01-01 DOI: 10.2174/1874364101509010104
Arif O Khan

Glaucoma in children differs from adult-onset disease and typically requires surgical intervention. However, affected children exhibit a spectrum of disease severity and prospective data guiding the choice of operation are lacking. This article reviews common procedures and a surgical approach to pediatric glaucoma.

儿童青光眼不同于成人发病疾病,通常需要手术干预。然而,受影响的儿童表现出一系列疾病的严重程度,缺乏指导手术选择的前瞻性数据。本文回顾了治疗小儿青光眼的常用方法和手术方法。
{"title":"A Surgical Approach to Pediatric Glaucoma.","authors":"Arif O Khan","doi":"10.2174/1874364101509010104","DOIUrl":"https://doi.org/10.2174/1874364101509010104","url":null,"abstract":"<p><p>Glaucoma in children differs from adult-onset disease and typically requires surgical intervention. However, affected children exhibit a spectrum of disease severity and prospective data guiding the choice of operation are lacking. This article reviews common procedures and a surgical approach to pediatric glaucoma. </p>","PeriodicalId":46347,"journal":{"name":"Open Ophthalmology Journal","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2015-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d2/39/TOOPHTJ-9-104.PMC4460229.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33383144","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
HRT for the Diagnosis and Detection of Glaucoma Progression. HRT对青光眼进展的诊断和检测。
IF 0.3 Q3 Medicine Pub Date : 2015-05-15 eCollection Date: 2015-01-01 DOI: 10.2174/1874364101509010058
Jessica S Maslin, Kaweh Mansouri, Syril K Dorairaj

Confocal scanning laser ophthalmoscopy through the Heidelberg Retina Tomograph (HRT) provides a rapid, safe, noncontact, and noninvasive imaging of the optic disc in three-dimensions, and provides precise detailed information about the optic disc beyond that which the clinical exam can measure. The HRT I was developed for research purposes only and was not used clinically. The HRT II was developed to be user-friendly, more rapid, and was used as an adjunct to clinical examination in the detection and progression of glaucoma. One of the main pitfalls of the HRT II was that it was operator-dependent. The HRT III was developed to be operator-independent. Initially the Moorsfield Regression Analysis provided the analysis of the stereometric optic disc parameters. The Glaucoma Probability Score, given its ease of use, operator-independence, and rapidity of use, soon gained popularity. Numerous studies have compared these two methods of analysis, with the conclusion that the Glaucoma Probability Score provides a higher sensitivity and a lower specificity than the Moorsfield Regression Analysis, which may indicate that it has potential as a screening test for glaucoma. However, there is no consensus on the use of the Glaucoma Probability Score as a screening test for glaucoma. While HRT data may be useful as a clinical adjunct in the screening and diagnosis of glaucoma, it should ultimately only be used to support clinical examination.

通过海德堡视网膜断层扫描仪(HRT)的共聚焦扫描激光眼科检查提供了快速、安全、非接触和无创的视盘三维成像,并提供了临床检查无法测量的视盘的精确详细信息。HRT I仅为研究目的而开发,未在临床上使用。HRT II被开发为更方便用户,更快速,并被用作青光眼检测和进展的临床检查的辅助手段。HRT II的主要缺陷之一是依赖于作业者。HRT III是独立于作业者的。最初的Moorsfield回归分析提供了立体视盘参数的分析。青光眼概率评分,由于其易于使用,操作独立,使用迅速,很快得到普及。大量的研究对这两种分析方法进行了比较,结论是青光眼概率评分法比Moorsfield回归分析具有更高的敏感性和更低的特异性,这可能表明它有潜力作为青光眼的筛查试验。然而,对于使用青光眼概率评分作为青光眼的筛查试验尚无共识。虽然HRT数据可能作为青光眼筛查和诊断的临床辅助手段,但它最终应仅用于支持临床检查。
{"title":"HRT for the Diagnosis and Detection of Glaucoma Progression.","authors":"Jessica S Maslin,&nbsp;Kaweh Mansouri,&nbsp;Syril K Dorairaj","doi":"10.2174/1874364101509010058","DOIUrl":"https://doi.org/10.2174/1874364101509010058","url":null,"abstract":"<p><p>Confocal scanning laser ophthalmoscopy through the Heidelberg Retina Tomograph (HRT) provides a rapid, safe, noncontact, and noninvasive imaging of the optic disc in three-dimensions, and provides precise detailed information about the optic disc beyond that which the clinical exam can measure. The HRT I was developed for research purposes only and was not used clinically. The HRT II was developed to be user-friendly, more rapid, and was used as an adjunct to clinical examination in the detection and progression of glaucoma. One of the main pitfalls of the HRT II was that it was operator-dependent. The HRT III was developed to be operator-independent. Initially the Moorsfield Regression Analysis provided the analysis of the stereometric optic disc parameters. The Glaucoma Probability Score, given its ease of use, operator-independence, and rapidity of use, soon gained popularity. Numerous studies have compared these two methods of analysis, with the conclusion that the Glaucoma Probability Score provides a higher sensitivity and a lower specificity than the Moorsfield Regression Analysis, which may indicate that it has potential as a screening test for glaucoma. However, there is no consensus on the use of the Glaucoma Probability Score as a screening test for glaucoma. While HRT data may be useful as a clinical adjunct in the screening and diagnosis of glaucoma, it should ultimately only be used to support clinical examination. </p>","PeriodicalId":46347,"journal":{"name":"Open Ophthalmology Journal","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2015-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/81/f3/TOOPHTJ-9-58.PMC4460217.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33383779","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
The Use of Spectral-Domain Optical Coherence Tomography to Detect Glaucoma Progression. 使用光谱域光学相干断层扫描检测青光眼进展。
IF 0.3 Q3 Medicine Pub Date : 2015-05-15 eCollection Date: 2015-01-01 DOI: 10.2174/1874364101509010078
Ricardo Y Abe, Carolina P B Gracitelli, Felipe A Medeiros

Detection of progression and measurement of rates of change is at the core of glaucoma management, and the use of Spectral Domain Optical Coherence Tomography (SD-OCT) has significantly improved our ability to evaluate change in the disease. In this review, we critically assess the existing literature on the use of SD-OCT for detecting glaucoma progression and estimating rates of change. We discuss aspects related to the reproducibility of measurements, their accuracy to detect longitudinal change over time, and the effect of aging on the ability to detect progression. In addition, we discuss recent studies evaluating the use of combined structure and function approaches to improve detection of glaucoma progression.

检测进展和测量变化率是青光眼治疗的核心,光谱域光学相干断层扫描(SD-OCT)的使用显著提高了我们评估疾病变化的能力。在这篇综述中,我们批判性地评估了SD-OCT用于检测青光眼进展和估计变化率的现有文献。我们讨论了与测量的可重复性、检测随时间纵向变化的准确性以及老化对检测进展能力的影响有关的方面。此外,我们讨论了最近的研究评估使用结合结构和功能的方法来提高青光眼进展的检测。
{"title":"The Use of Spectral-Domain Optical Coherence Tomography to Detect Glaucoma Progression.","authors":"Ricardo Y Abe,&nbsp;Carolina P B Gracitelli,&nbsp;Felipe A Medeiros","doi":"10.2174/1874364101509010078","DOIUrl":"https://doi.org/10.2174/1874364101509010078","url":null,"abstract":"<p><p>Detection of progression and measurement of rates of change is at the core of glaucoma management, and the use of Spectral Domain Optical Coherence Tomography (SD-OCT) has significantly improved our ability to evaluate change in the disease. In this review, we critically assess the existing literature on the use of SD-OCT for detecting glaucoma progression and estimating rates of change. We discuss aspects related to the reproducibility of measurements, their accuracy to detect longitudinal change over time, and the effect of aging on the ability to detect progression. In addition, we discuss recent studies evaluating the use of combined structure and function approaches to improve detection of glaucoma progression. </p>","PeriodicalId":46347,"journal":{"name":"Open Ophthalmology Journal","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2015-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ce/54/TOOPHTJ-9-78.PMC4460225.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33383781","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 31
期刊
Open Ophthalmology Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1